Treatment of Ear Infections in Adults
For adults with ear infections, topical antibiotics with or without corticosteroids are the first-line treatment for otitis externa, while systemic antibiotics may be needed for acute otitis media or complicated infections. 1
Types of Ear Infections in Adults
Otitis Externa (Outer Ear Infection)
- Most common ear infection in adults, with approximately 10% lifetime incidence 1
- Typically caused by Pseudomonas aeruginosa and Staphylococcus aureus; less commonly by fungal pathogens like Aspergillus or Candida 1
- Presents with otalgia (ear pain), tenderness, fever, and ear discharge 1
- Diagnosis is largely clinical, requiring at least 1 characteristic symptom (otalgia, otorrhea, or itchiness) and 2 signs (tragal tenderness, ear canal edema, ear canal erythema, or wet debris) 1
Acute Otitis Media (Middle Ear Infection)
- Less common in adults than in children 1
- Typically caused by Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis 2
- Presents with sudden onset of fever, otalgia, and sometimes otorrhea 1
- May cause conductive hearing loss and show a reddened, bulging tympanic membrane on examination 1
Treatment Algorithm for Ear Infections in Adults
1. Otitis Externa (Outer Ear Infection)
First-line treatment:
- Topical antibiotics with or without corticosteroids 1, 3
- Clean and dry the ear canal mechanically (via suction or gentle wiping) before application 3
- Topical therapy delivers 100-1000 times higher antibiotic concentration than systemic therapy 1
- Ofloxacin otic solution 0.3% is FDA-approved for otitis externa in adults due to E. coli, P. aeruginosa, and S. aureus 4
- Combination antibiotic-corticosteroid drops may provide faster pain relief 1, 3
Important considerations:
- Do not prescribe systemic antibiotics for uncomplicated otitis externa unless there is extension outside the ear canal 1
- For pain management, use analgesics for the first 48-72 hours until topical therapy takes effect 1
- If no improvement within 48-72 hours, consider bacterial or fungal culture 3
- For fungal infections (otomycosis), the primary treatment is cleaning and topical antifungal medication 3
2. Acute Otitis Media (Middle Ear Infection)
Treatment approach:
- In adults, AOM is rare but uses the same treatment principles as in children 1
- Systemic antibiotics are typically indicated 1
Alternative antibiotics:
- For penicillin allergy: macrolides, pristinamycin, or doxycycline 1
- For treatment failure or high-risk situations: amoxicillin-clavulanate, second or third generation cephalosporins 1
Special Considerations
Factors that modify management:
- Diabetes or immunocompromised state: Higher risk for otomycosis and necrotizing otitis externa; may require systemic antibiotics in addition to topical therapy 1
- Prior radiotherapy: May require systemic antimicrobials 1
- Non-intact tympanic membrane or tympanostomy tubes: Requires special consideration for medication choice 1
- Ofloxacin otic solution is specifically approved for chronic suppurative otitis media with perforated tympanic membranes 4
Warning signs requiring specialist referral:
- Persistent symptoms despite appropriate therapy 1
- Signs of complications: mastoid tenderness, headache, vertigo, meningismus, neck rigidity, or neurological deficits 1
- Suspected necrotizing otitis externa (particularly in diabetic or immunocompromised patients) 1
Monitoring and Follow-up
- Symptoms of uncomplicated otitis externa should improve within 48-72 hours of initiating appropriate topical therapy 1
- If symptoms persist beyond this timeframe, consider:
Common Pitfalls to Avoid
- Using systemic antibiotics for uncomplicated otitis externa (increases risk of antibiotic resistance) 1, 6
- Failing to clean and dry the ear canal before applying topical medications 3
- Not considering fungal infection when standard treatment fails 1
- Missing the diagnosis of necrotizing otitis externa in high-risk patients 1
- Using ototoxic drops in patients with perforated tympanic membranes (except for approved medications like ofloxacin) 1, 4